Treatment of chemotherapy-induced neutropenia with pegylated recombinant human granulocyte colony-stimulating factor: A multi-center randomized controlled phase II clinical study

National Medical Journal of China

Volumn 86, Issue 48, 2006, Pages 3414-3419

  Shi, Yuan Kai ^a   He, Xiao Hui ^b   Yang, Sheng ^b   Wang, Hua Qing ^b   Jiang, Ze Fei ^b   Zhu, Yun Zhong ^b   Ke, Xiao Yan ^b   Zhang, Yang ^b   Liu, Yun Peng ^b   Zhang, Wei Jing ^b   Wang, Zhao ^b   Shi, Qing Zhi ^b   Xie, Xiao Dong ^b   Zhang, He Long ^b   Wang, Jie Jun ^b   Luo, De Yun ^b   Zheng, Qing Shan ^b   Sun, Rui Yan ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b NONE

Author keywords

Clinical trials, phase II; Drug therapy, combination; Granulocyte colony stimulating factor, recombinant; Neutropenia; Polyethylene glycols

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ARTHRALGIA; ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; INJECTION SITE PAIN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL PAIN; NEUTROPENIA; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CROSS-OVER STUDIES; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; INJECTIONS, SUBCUTANEOUS; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEUTROPENIA; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33847392162     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chinese source.
2. Shang X, Yin H, Lu A, et al. Application of recombinant human granulocyte colony stimulating factor in children with acute myeloid leukemia. Chin Med J, 1999 112:620-622.
3. Ke X, Yang Y, Zhao X, et al. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors. Chin Med J 2001,114:196-199.
4. Chinese source.
5. Chinese source.
6. Chinese source.
7. Chinese source.
8. Holmes FA, Jones SE, O'Shaughnessy J, et al. Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer. Ann Oncol, 2002,13: 903-909.
9. Holmes FA, O'Shaughnessy JA, VukeIja S, et al. Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol, 2002,20:727-731.
10. Layton JE, Hockman H, Sheridan WP, et al. Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood, 1989,74:1303-1307.
11. Roskos LK, Yank B, Schwab G, et al. A cytokinetic model of r-metHUG-CSF-SD/01 mediated granulopoiesis and "self-regulation" of SD-01, elimination in non-small cell lung cancer patients. Blood, 1998,92: 507a.
12. Nicola NA, Peterson L, Hilton DJ, et al. Cellular processing of murine colony-stimulating factor (Multi-CSF, GM-CSF, G-CSF) receptors by normal hemopoietic cells and cell lines. Growth Factors, 1988,1:41-49.
13. Vogel CL, Wojtukiewicz MZ, Carroll RR, et al. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol, 2005,23:1178-1184.
14. Lyman GH, Kuderer NM. The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropenia. Crit Rev Oncol Hematol, 2004,50:129-146.
15. Calhoun EA, Schumock GT, McKoy JM,et al. Granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer: the 40% rule revisited. Pharmacoeconomics, 2005,23:767-775.